ProfileGDS2971 / 1.1.20.5
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 45% 39% 14% 47% 50% 62% 68% 65% 74% 47% 26% 44% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.033744945
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.087735839
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.57066914
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.025308547
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.0024045550
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.13164662
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.29692168
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.24196565
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.39590174
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.0070324247
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.35899526
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.019444244